American Medical Device Summit
PharmaLex France has been approved for the Research Tax Credit for the next 3 years
We are now able to offer our customers a real research tax credit benefit on a yearly basis.
For more information please contact:
Sophie Guillaume
General Manager
PharmaLex France
contact@pharmalex.com
Patrick Larcier
Senior Director, Drug Development & Vigilance
PharmaLex France
contact@pharmalex.com
Related posts
